HomeAI · summaries
Storia in 3 fonti
Assay measures eMTBR-tau as biomarker for tau tangle burden in Alzheimer’s diagnosis
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International Conference. Definitive diagnoses require evidence of amyloid plaques and tau neurofibrillary tangles, Alamar Biosciences said in a press release. Blood tests can measure p-tau217, which indicates amyloid
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at…
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference®…
- ·
healio.com
Assay measures eMTBR-tau as biomarker for tau tangle burden in Alzheimer’s diagnosis
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association…
- ·
cnn.com
New Alzheimer’s blood test may be promising but is not yet ready for widespread use | CNN
Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use the test, however, is unclear.